• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

DGKD

The adenosine A2A receptor (A2AR) is expressed in immune cells aswell

March 11, 2019 by Katherine Lewis Leave a Comment

The adenosine A2A receptor (A2AR) is expressed in immune cells aswell as heart and lung tissue and continues to be intensively studied being a therapeutic target for multiple disease indications. the tiny molecule ZM was an excellent A2AR antagonist in mice, in keeping with the chance that Fc connection can improve pharmacokinetic and/or pharmacodynamic properties … [Read more…]

Posted in: Blogging Tagged: DGKD, VX-680

The Erythrina alkaloids erysodine and dihydro–erythroidine (DHE) are potent and selective

August 2, 2018 by Katherine Lewis Leave a Comment

The Erythrina alkaloids erysodine and dihydro–erythroidine (DHE) are potent and selective competitive inhibitors of 42 nicotinic acetylcholine receptors (nAChRs), but small is well known about the molecular determinants from the sensitivity of the receptor subtype to inhibition by this class of antagonists. nevertheless, just 4Trp182 was expected to contact destined antagonist, recommending 4Tyr230, 2Trp82, and … [Read more…]

Posted in: Blogging Tagged: DGKD, Spinorphin IC50

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by